Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 67

Sort by

Sort Order Select

Journal Articles

Bleeding Risk in Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies

Yimin Pearl Wang, BSc, Rohan Kehar, MDMSc,FRCPC, Alla Iansavitchene, BSc, Alejandro Lazo-Langner, MD MSc

Blood (2019) 134 (Supplement_1): 3672.

https://doi.org/10.1182/blood-2019-123870

Published: 2019

Journal Articles

Effectiveness and Safety of Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Patients with Active Cancer Therapy and Non Valvular Atrial Fibrillation

Pável E Olivera, MD, César A Velasquez, MD, Desirée Campoy, MD, Gonzalo Artaza, MD, Tania Canals, MD, Katia Flores, MD, Silvia Ruiz, MD, Alessandra Comai, MD, Erik A Johansson, MD, Gabriela S Ene, MD PhD, Gabriela Bastidas, MD, Maricel Subira, MD PhD, Jorge Sierra, MD, Ramón Salinas, MD PhD

Blood (2019) 134 (Supplement_1): 3661.

https://doi.org/10.1182/blood-2019-128300

Published: 2019

Journal Articles

Rivaroxaban Reduces the Levels of Extracellular Vesicles in Patients with Venous Thromboembolism and Non-Valvular Atrial Fibrillation

Sarah Kelliher, MBBS, Luisa Weiss, MSc, Paulina Szklanna, PhD, Karl Egan, PhD, Tadhg Prendiville, MB BCh BAO, Eric Moran, MB BCh BAO, Georgi Petrov, MB BCh BAO, Alfonso Blanco, PhD, Aine Lennon, MSc, Sean Murphy, MD, John Keaney, MD, Fionnuala Ni Ainle, PhD, Patricia Maguire, PhD

Blood (2019) 134 (Supplement_1): 2437.

https://doi.org/10.1182/blood-2019-126166

Published: 2019

Journal Articles

Anticoagulation Challenges in Hematogeriatrics: Effectiveness and Safety of Direct Oral Anticoagulants Vs Vitamin k Antagonist in Elderly with Atrial Fibrillation

Desirée Campoy, MD, Gonzalo Artaza, MD, César A Velasquez, MD, Tania Canals, MD, Erik A Johansson, MD, Katia Flores, MD, Gabriela Bastidas, MD, Silvia Ruiz, MD, Gabriela S Ene, MD PhD, Alessandra Comai, MD, Maricel Subira, MD PhD, Ramón Salinas, MD PhD, Jorge Sierra, MD, Pável E Olivera, MD

Blood (2019) 134 (Supplement_1): 1162.

https://doi.org/10.1182/blood-2019-125150

Published: 2019

Journal Articles

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

Jordan K Schaefer, MD, Yun Li, PhD, Xiaowen Kong, MA, Tina Alexandris-Souphis, RN, Mona A Ali, PharmD, Brian Haymart, RN, MS, Scott Kaatz, DO, MSc, Eva Kline-Rogers, RN, MS, Jay H Kozlowski, MD, Gregory D Krol, Sahana R Shankar, Suman L Sood, MD, James B Froehlich, MD MPH, Geoffrey D Barnes, MD MSc

Blood (2019) 134 (Supplement_1): 787.

https://doi.org/10.1182/blood-2019-122526

Published: 2019

Journal Articles

Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study

Alfonso J Tafur, MD MS, Na Li, PhD, Nathan Clark, PharmD, Sam Schulman, MD PhD FRCPC, Alex Spyropoulos, MD, Joseph A Caprini, MD MS, FACS, RVT, James Douketis, MD

Blood (2019) 134 (Supplement_1): 710.

https://doi.org/10.1182/blood-2019-125292

Published: 2019

Journal Articles

Treatment Failure in Patients Receiving Direct Oral Anticoagulants: Clinical Management and Outcomes from a Single-Center Review of 59 Consecutive Patients

Graham McIlroy, MD, Neil Smith, MD FRCPath, Anand Lokare, MD FRCPath, MRCP, Karen Beale, Charalampos Kartsios, MD

Blood (2018) 132 (Supplement 1): 5058.

https://doi.org/10.1182/blood-2018-99-111108

Published: 2018

Journal Articles

Direct Oral Anticoagulants and Mortality in Atrial Fibrillation

Martin Ellis, MD, Sergienko Ruslan, Hammerman Ariel, Sari Greenberg-Dotan, Erez Battat, Orly Hamburger-Avnery, MD, Dan Greenberg, Arbel Ronen

Blood (2018) 132 (Supplement 1): 5061.

https://doi.org/10.1182/blood-2018-99-111182

Published: 2018

Journal Articles

Diffuse Alveolar Hemorrhage Secondary to Direct Oral Anticoagulants: A Systematic Review of Reported Cases

Fawzi Abu Rous, MD, Abdullah al-Abcha, Layan El-khatib, Shiva Shrotriya, MD MPH, Prajwal Dhakal, MBBS

Blood (2018) 132 (Supplement 1): 5069.

https://doi.org/10.1182/blood-2018-99-115545

Published: 2018

Journal Articles

Efficacy and Safety of Direct Oral Factor Xa Inhibitors in 795 Morbidly Obese Patients

Margarita Kushnir, MD, Yun Choi, MD, Ruth Eisenberg, MS, Devika Rao, MD, Seda Tolu, MD, Jackson Gao, MD, Wenzhu Mowrey, PhD, Henny Heisler Billett, MD

Blood (2018) 132 (Supplement 1): 423.

https://doi.org/10.1182/blood-2018-99-116396

Published: 2018

Journal Articles

Thrombotic and Bleeding Outcomes Following Perioperative Interruption of Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation - a Comparative Analysis

Joseph R. Shaw, MD, Tinghua Zhang, M.Sc., Gregoire Le Gal, MD PhD, James Douketis, MD, Marc Carrier, MD MSc

Blood (2018) 132 (Supplement 1): 1234.

https://doi.org/10.1182/blood-2018-99-111698

Published: 2018

Journal Articles

Comparative Risk of Acute Kidney Injury with Oral Anticoagulant Use Among Patients with Nonvalvular Atrial Fibrillation

Adi J. Klil-Drori, MD, Laurent Azoulay, PhD, Rui Nie, MSc, Christel Renoux, MD, PhD, Sharon J. Nessim, MD, MSc, Kristian B. Filion, PhD

Blood (2017) 130 (Supplement 1): 700.

https://doi.org/10.1182/blood.V130.Suppl_1.700.700

Published: 2017

Journal Articles

Data of Real-Life Anticoagulant Treatment in Patients Diagnosed with Nonvalvular Atrial Fibrillation and Secondary Prevention of Venous Thromboembolic Disease with Edoxaban: Experience in Our Center

Maria Almudena Garcia Ruiz, Marta Rivas Luque, Pablo Romero Garcia, MDCINE Resident, Manuel Jurado, MD PhD

Blood (2017) 130 (Supplement 1): 4920.

https://doi.org/10.1182/blood.V130.Suppl_1.4920.4920

Published: 2017

Journal Articles

From a DOAC to Warfarin: Reasons Why Patients Switch

Aisling Barrett, MB, BCh, BAO, MRCPI, Sahar Khan, MRCPI, Margaret Moore, RGN, Patricia Ferrins, RGN, BSc, Jeremy Sargent, FRCPath, Patrick Thornton, Philip Murphy, John Quinn

Blood (2017) 130 (Supplement 1): 4910.

https://doi.org/10.1182/blood.V130.Suppl_1.4910.4910

Published: 2017

Journal Articles

Idarucizumab for Reversing Anticoagulation in Patients Treated with Dabigatran: Experience in Our Center

Estefania Morente Constatin, MDCINE Resident, Marta Rivas Luque, Pablo Romero Garcia, MDCINE Resident, Maria Almudena Garcia-Ruiz, Manuel Jurado, MD PhD

Blood (2017) 130 (Supplement 1): 4923.

https://doi.org/10.1182/blood.V130.Suppl_1.4923.4923

Published: 2017

Journal Articles

Risk of Intracranial Hemorrhage with Direct Oral Anticoagulants: A Traditional and Network Meta-Analysis

Zachary Wolfe, MD, Fahad Nasir, MD, Charumathi Subramanian, MD, Safi Khan, MD, Bradley W. Lash, MD

Blood (2017) 130 (Supplement 1): 2387.

https://doi.org/10.1182/blood.V130.Suppl_1.2387.2387

Published: 2017

Journal Articles

Effectiveness and Safety of the 15 Mg Dose of Rivaroxaban Compared with Vitamin k Antagonists in Patients with Atrial Fibrillation: Results from a Cohort Study in the Nationwide French Claims and Hospitalization Database (SNIIRAM)

Laurent Fauchier, MD PhD, Patrick Blin, MD PhD, Frédéric Sacher, MD PhD, Caroline Dureau-Pournin, MSc, Marie-Agnes Bernard, MSc, Regis Lassalle, Cécile Droz-Perroteau, PhD, Jean Dallongeville, MD PhD, Nicholas Moore, MD PhD FRCP

Blood (2017) 130 (Supplement 1): 2390.

https://doi.org/10.1182/blood.V130.Suppl_1.2390.2390

Published: 2017

Journal Articles

Effectiveness and Safety of Rivaroxaban Vs. Warfarin in Patients with Nonvalvular Atrial Fibrillation and Moderate-to-Severe Chronic Kidney Disease

Craig I. Coleman, PharmD, Brandon K. Martinez, PharmD, Alexander G. G. Turpie, MD, Nitesh Sood, MD, Thomas J. Bunz, PharmD, PhD, Reinhold Kreutz, PhD

Blood (2017) 130 (Supplement 1): 2393.

https://doi.org/10.1182/blood.V130.Suppl_1.2393.2393

Published: 2017

Journal Articles

Adverse Events in Patients with Cancer Treated with Direct Oral Anticoagulants and Cancer Therapy

Huong L Truong, PharmD, Audrea Szabatura, PharmD, Houry Leblebjian, PharmD, Christy Harris, PharmD, Jean M. Connors, BA,MD

Blood (2017) 130 (Supplement 1): 2396.

https://doi.org/10.1182/blood.V130.Suppl_1.2396.2396

Published: 2017

Journal Articles

Safety and Efficacy of Direct-Acting Oral Anticoagulation (DOACs) Based on BMI

Kimberley Doucette, Bhavisha Patel, MD, Anusha Vakiti, Kelly W. Fitzpatrick, MD

Blood (2017) 130 (Supplement 1): 3715.

https://doi.org/10.1182/blood.V130.Suppl_1.3715.3715

Published: 2017

NARROW

Bleeding Risk in Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies

Effectiveness and Safety of Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Patients with Active Cancer Therapy and Non Valvular Atrial Fibrillation

Rivaroxaban Reduces the Levels of Extracellular Vesicles in Patients with Venous Thromboembolism and Non-Valvular Atrial Fibrillation

Anticoagulation Challenges in Hematogeriatrics: Effectiveness and Safety of Direct Oral Anticoagulants Vs Vitamin k Antagonist in Elderly with Atrial Fibrillation

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study

Treatment Failure in Patients Receiving Direct Oral Anticoagulants: Clinical Management and Outcomes from a Single-Center Review of 59 Consecutive Patients

Direct Oral Anticoagulants and Mortality in Atrial Fibrillation

Diffuse Alveolar Hemorrhage Secondary to Direct Oral Anticoagulants: A Systematic Review of Reported Cases

Efficacy and Safety of Direct Oral Factor Xa Inhibitors in 795 Morbidly Obese Patients

Thrombotic and Bleeding Outcomes Following Perioperative Interruption of Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation - a Comparative Analysis

Comparative Risk of Acute Kidney Injury with Oral Anticoagulant Use Among Patients with Nonvalvular Atrial Fibrillation

Data of Real-Life Anticoagulant Treatment in Patients Diagnosed with Nonvalvular Atrial Fibrillation and Secondary Prevention of Venous Thromboembolic Disease with Edoxaban: Experience in Our Center

From a DOAC to Warfarin: Reasons Why Patients Switch

Idarucizumab for Reversing Anticoagulation in Patients Treated with Dabigatran: Experience in Our Center

Risk of Intracranial Hemorrhage with Direct Oral Anticoagulants: A Traditional and Network Meta-Analysis

Effectiveness and Safety of the 15 Mg Dose of Rivaroxaban Compared with Vitamin k Antagonists in Patients with Atrial Fibrillation: Results from a Cohort Study in the Nationwide French Claims and Hospitalization Database (SNIIRAM)

Effectiveness and Safety of Rivaroxaban Vs. Warfarin in Patients with Nonvalvular Atrial Fibrillation and Moderate-to-Severe Chronic Kidney Disease

Adverse Events in Patients with Cancer Treated with Direct Oral Anticoagulants and Cancer Therapy

Safety and Efficacy of Direct-Acting Oral Anticoagulation (DOACs) Based on BMI

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only